PTEN and cancer: Some of its individual components, such as p110α and Pten, are among the most frequently mutated genes in cancer; however, many other lesions that activate this pathway are also involved in tumorigenesis (oncogenic Ras, AKT, loss of LKB1, etc.)[125].